A5083303088- Lipoproteins and Cardiovascular Health
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Systemic Lupus Erythematosus Research
- Pharmaceutical Economics and Policy
- Cancer, Lipids, and Metabolism
- Atherosclerosis and Cardiovascular Diseases
- Inflammatory mediators and NSAID effects
- Long-Term Effects of COVID-19
- Liver Disease Diagnosis and Treatment
- Hepatitis Viruses Studies and Epidemiology
- Health Systems, Economic Evaluations, Quality of Life
- Genetic factors in colorectal cancer
- Liver Diseases and Immunity
D•A•CH-Gesellschaft
2022-2023
Berlin Institute of Health at Charité - Universitätsmedizin Berlin
2023
European Atherosclerosis Society
2021
Charité - Universitätsmedizin Berlin
2015
Background The role of regulatory CD4 T cells (Treg) in immune-mediated liver disease is still under debate. It remains disputed whether Treg suppress cell-mediated hepatitis vivo and hepatic are functional patients with autoimmune hepatitis. Methods We used TF-OVA mice, which express ovalbumin hepatocytes, to investigate the impact a model isolated from inflamed livers mice were tested for their functionality vitro. By employing double transgenic TF-OVAxDEREG (DEpletion REGulatory cells) we...
Abstract Background The severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) pandemic causes a high burden of and long-term morbidity mortality worldwide despite global efforts in containment, prophylaxis, therapy. With unprecedented speed, the scientific community has generated pivotal insights into pathogen host response evoked by infection. However, deeper characterization pathophysiology pathology remains priority to reduce coronavirus disease 2019 (COVID-19). Methods NAPKON-HAP...
Background and aims: Familial hypercholesterolemia (FH) is amongst the most common genetic disorders in primary care. It estimated that at 15 percent of patients are diagnosed only a minority them reach low- density lipoprotein cholesterol (LDL-C) targets. This analysis German Cascade Screening Registry for High Cholesterol (CaRe High) examines a) status lipid management, b) predictors treatment strategies, c) achievement target values according to ESC/EAS dyslipidemia guidelines. Methods:...